Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 131, Issue 22
May 31 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

Lymphoid Neoplasia
Liquid biopsy for Hodgkin: a game changer?
Kieron Dunleavy
View Articletitled, Liquid biopsy for Hodgkin: a game changer?
CLINICAL TRIALS AND OBSERVATIONS
Speaking volumes about volumes
Clinical Trials & Observations
Bruce D. Cheson
View Articletitled, Speaking volumes about volumes
TRANSPLANTATION
Non-HLA genetic mismatches and BMT outcome
Philip J. Lupo
View Articletitled, Non-HLA genetic mismatches and BMT outcome

PLENARY PAPER

PLENARY PAPER
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Valeria Spina,Alessio Bruscaggin,Annarosa Cuccaro,Maurizio Martini,Martina Di Trani,Gabriela Forestieri,Martina Manzoni,Adalgisa Condoluci,Alberto Arribas,Lodovico Terzi-Di-Bergamo,Silvia Laura Locatelli,Elisa Cupelli,Luca Ceriani,Alden A. Moccia,Anastasios Stathis,Luca Nassi,Clara Deambrogi,Fary Diop,Francesca Guidetti,Alessandra Cocomazzi,Salvatore Annunziata,Vittoria Rufini,Alessandro Giordano,Antonino Neri,Renzo Boldorini,Bernhard Gerber,Francesco Bertoni,Michele Ghielmini,Georg Stüssi,Armando Santoro,Franco Cavalli,Emanuele Zucca,Luigi Maria Larocca,Gianluca Gaidano,Stefan Hohaus,Carmelo Carlo-Stella,Davide Rossi
View Articletitled, Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Supplemental data

PERSPECTIVE

The role of JAK2 inhibitors in MPNs 7 years after approval
Francesco Passamonti,Margherita Maffioli
View Articletitled, The role of JAK2 inhibitors in MPNs 7 years after approval

REVIEW ARTICLE

14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling
Yunfeng Chen,Zaverio M. Ruggeri,Xiaoping Du
View Articletitled, 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling

CLINICAL TRIALS AND OBSERVATIONS

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study
Clinical Trials & Observations Brief Report
Anne Ségolène Cottereau,Annibale Versari,Stefano Luminari,Jehan Dupuis,Loïc Chartier,René-Olivier Casasnovas,Alina Berriolo-Riedinger,Massimo Menga,Corinne Haioun,Hervé Tilly,Vittoria Tarantino,Massimo Federico,Gilles Salles,Judith Trotman,Michel Meignan
View Articletitled, Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study
Supplemental data

LYMPHOID NEOPLASIA

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci,Erik Ladewig,Gianluca Schiavoni,Alex Penson,Elisabetta Fortini,Valentina Pettirossi,Yuchun Wang,Ariele Rosseto,Alessandra Venanzi,Sofija Vlasevska,Roberta Pacini,Simonetta Piattoni,Alessia Tabarrini,Alessandra Pucciarini,Barbara Bigerna,Alessia Santi,Alessandro M. Gianni,Simonetta Viviani,Antonello Cabras,Stefano Ascani,Barbara Crescenzi,Cristina Mecucci,Laura Pasqualucci,Raul Rabadan,Brunangelo Falini
View Articletitled, Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Supplemental data
Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy
Rina Nishii,Takaya Moriyama,Laura J. Janke,Wenjian Yang,Chase C. Suiter,Ting-Nien Lin,Lie Li,Kentaro Kihira,Hidemi Toyoda,Ute Hofmann,Matthias Schwab,Masatoshi Takagi,Tomohiro Morio,Atsushi Manabe,Shirley Kham,Nan Jiang,Karen R. Rabin,Motohiro Kato,Katsuyoshi Koh,Allen Eng-Juh Yeoh,Hiroki Hori,Jun J. Yang
View Articletitled, Preclinical evaluation of <em>NUDT15</em>-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy
Supplemental data
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
Clinical Trials & Observations
Cecilie Utke Rank,Nina Toft,Ruta Tuckuviene,Kathrine Grell,Ove Juul Nielsen,Thomas Leth Frandsen,Hanne Vibeke Hansen Marquart,Birgitte Klug Albertsen,Ulf Tedgård,Helene Hallböök,Ellen Ruud,Kirsten Brunsvig Jarvis,Petter Quist-Paulsen,Pasi Huttunen,Ulla Wartiovaara-Kautto,Ólafur Gísli Jónsson,Sonata Saulyte Trakymiene,Laimonas Griškevičius,Kadri Saks,Mari Punab,Kjeld Schmiegelow
View Articletitled, Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
Supplemental data

MYELOID NEOPLASIA

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML
Brief Report
David G. J. Cucchi,Barbara Denys,Gertjan J. L. Kaspers,Jeroen J. W. M. Janssen,Gert J. Ossenkoppele,Valérie de Haas,C. Michel Zwaan,Marry M. van den Heuvel-Eibrink,Jan Philippé,Tamás Csikós,Zinia Kwidama,Barbara de Moerloose,Eveline S. J. M. de Bont,Birgit I. Lissenberg-Witte,Sonja Zweegman,Femke Verwer,Karl Vandepoele,Gerrit Jan Schuurhuis,Edwin Sonneveld,Jacqueline Cloos
View Articletitled, RNA-based <em>FLT3</em>-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML
Supplemental data

TRANSPLANTATION

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation
Qianqian Zhu,Li Yan,Qian Liu,Chi Zhang,Lei Wei,Qiang Hu,Leah Preus,Alyssa I. Clay-Gilmour,Kenan Onel,Daniel O. Stram,Loreall Pooler,Xin Sheng,Christopher A. Haiman,Xiaochun Zhu,Stephen R. Spellman,Marcelo Pasquini,Philip L. McCarthy,Song Liu,Theresa Hahn,Lara E. Sucheston-Campbell
View Articletitled, Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation
Supplemental data

LETTERS TO BLOOD

MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association
Clinical Trials & Observations
Neal J. Weinreb,Pramod K. Mistry,Barry E. Rosenbloom,Madhav V. Dhodapkar
View Articletitled, MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens
Clinical Trials & Observations
Eric A. Severson,Gregory M. Riedlinger,Caitlin F. Connelly,Jo-Anne Vergilio,Mendel Goldfinger,Shakti Ramkissoon,Garrett M. Frampton,Jeffrey S. Ross,Anthony Fratella-Calabrese,Laurie Gay,Siraj Ali,Vincent Miller,Julia Elvin,Mohammad Hadigol,Kim M. Hirshfield,Lorna Rodriguez-Rodriguez,Shridar Ganesan,Hossein Khiabanian
View Articletitled, Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens
Supplemental data

BLOOD WORK

Paroxysmal cold hemoglobinuria with acute renal failure
Emily Ximin Shao,Nina Raju
View Articletitled, Paroxysmal cold hemoglobinuria with acute renal failure
Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab
Ibrahim Aldoss,Joo Y. Song
View Articletitled, Extramedullary relapse of <em>KMT2A</em>(<em>MLL</em>)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab

ERRATA

Liang HPH, Kerschen EJ, Hernandez I, et al. EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood. 2015;125(18):2845-2854.
View Articletitled, Liang HPH, Kerschen EJ, Hernandez I, et al. EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. <em>Blood</em>. 2015;125(18):2845-2854.
Liang HPH, Kerschen EJ, Basu S, et al. Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. Blood. 2015;126(21):2415-2423.
View Articletitled, Liang HPH, Kerschen EJ, Basu S, et al. Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. <em>Blood</em>. 2015;126(21):2415-2423.
All Issues

Advertisement

Data mining for second malignancies after CAR-T
Silva A, Almeida ARM, Cachucho A, et al. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma. Blood. 2021;138(12):1040-1052.
MRD and EFS in pediatric T-lymphoblastic lymphoma
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement